RENE VALIENTE: Open Payments
NPI 1003965302 · COCONUT GROVE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,318 in 64 payments from 16 companies in 2025. Trend: 2023 $2,360 · 2024 $2,225 · 2025 $2,318
Food & beverage: $2,318
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 9 | $504 |
| Janssen Biotech, Inc. | 12 | $467 |
| UCB, Inc. | 10 | $246 |
| Incyte Corporation | 5 | $231 |
| E.R. Squibb & Sons, L.L.C. | 7 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $166 |
| Novartis Pharmaceuticals Corporation | 3 | $102 |
| ConvaTec Inc. | 3 | $90 |
| Lilly USA, LLC | 3 | $71 |
| PFIZER INC. | 2 | $68 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, OPZELURA, Sotyktu, SPEVIGO, COSENTYX, INNOVAMATRIX AC.
Industry payments across FL — which companies pay providers there.
